Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Sanchen Wan is a traditional Mongolian medicine (TMM) formulation developed and manufactured by Mengyao Pharmaceutical. It is an approved oral herbal product primarily utilized in pediatric care. The formulation is traditionally indicated for clearing heat, resolving toxins, and calming the nerves (sedation). It is commonly prescribed to treat symptoms such as high fever, cough, sore throat, and infantile convulsions or restlessness. As a traditional multi-herb formulation, its therapeutic effects are attributed to the synergistic actions of its constituent botanical and mineral ingredients, which typically include *Terminalia chebula*, *Bambusa textilis*, and *Cinnabaris*. It is regulated as a pharmaceutical product in China under the Mongolian medicine category.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Sanchen Wan.